Inhaled steroids with and without regular formoterol for asthma: serious adverse events-Reference-Cited by-同舟云学术

Inhaled steroids with and without regular formoterol for asthma: serious adverse events

Published:2019-09-25 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Janjua Sadia¹,Schmidt Stefanie²,Ferrer Montse³,Cates Christopher J⁴

Affiliation:

1. St George's, University of London; Cochrane Airways, Population Health Research Institute; London UK SW17 0RE

2. UroEvidence@Deutsche Gesellschaft für Urologie; Nestorstr. 8-9 (1. Hof) Berlin Germany 10709

3. IMIM (Hospital del Mar Medical Research Institute); Health Services Research Group; C/ Doctor Aiguader, 88 Barcelona Spain 08003

4. St George's, University of London; Population Health Research Institute; Cranmer Terrace London UK SW17 0RE

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006924.pub4/epdf/full

Reference254 articles.

1. AstraZeneca D5896C00022 A comparison of SYMBICORT pMDI with budesonide HFA pMDI in African American subjects with asthma astrazenecagrouptrials.pharmacm.com/ST/Submission/View?id=1588

2. Long-term cardiovascular safety, as evaluated by electrocardiographic monitoring, of budesonide/formoterol pressurized metered-dose inhaler in African-American patients with moderate to severe asthma [Abstract];Brown;Journal of Allergy and Clinical Immunology,2012

3. Long-term safety and asthma control measures with a budesonide/formoterol pressurized metered-dose inhaler in African American asthmatic patients: a randomised controlled trial;Brown;Journal of Allergy and Clinical Immunology,2012

4. Long-term safety of budesonide/formoterol pressurized metered-dose inhaler (PMDI) and budesonide PMDI In African-American patients with asthma: asthma exacerbations and adverse events [Abstract];Brown;American Journal of Respiratory and Critical Care Medicine,2011

5. AstraZeneca SD-039-0666 Symbicort high dose once daily in mild to moderate asthmatic patients astrazenecagrouptrials.pharmacm.com/ST/Submission/View?id=1012

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adoption and implementation of maintenance and reliever therapy for adults with moderate-to-severe asthma;Annals of Allergy, Asthma & Immunology;2024-09

2. An evidence gap map of interventions for noncommunicable diseases and risk factors among children and adolescents;Nature Medicine;2024-01

3. Analytical review of respiratory infections role in patients with chronic obstructive pulmonary disease and asthma. Part 2. Prevention of occurrence and severe course of respiratory infections;Profilakticheskaya meditsina;2024

4. Executive summary: Japanese guidelines for adult asthma (JGL) 2021;Allergology International;2023-04

5. Asthma and COPD: A Focus on β-Agonists – Past, Present and Future;Handbook of Experimental Pharmacology;2023